ArticleCancers2021

Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer.

Kübra Kaban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.